The stereoselectivity of the reversible binding interactions between the D- and L-tryptophan enantiomers and serum albumins of different animal species and fragments of human serum albumin (HSA) was investigated by applying three novel high performance liquid chromatographic (HPLC) arrangements. The separations were performed by means of 1) an achiral (diol-bond), 2) a chiral (bovine serum albumin-bond) silica gel sorbent, and 3) a column switching technique which uses both the diol- and HSA-bond HPLC stationary phases. A polarimetric detector and/or an ultraviolet (UV) spectrophotometer were used to monitor the separation process. HPLC arrangement 3 allowed the evaluation of enantioselective binding for D- and L-tryptophan to different albumins and albumin fragments. At present, column switching can be considered the technique of the broadest applicability for investigating the reversible binding interactions between a protein and drug enantiomers.

Download full-text PDF

Source
http://dx.doi.org/10.1002/(sici)1520-636x(1997)9:4<373::aid-chir10>3.0.co;2-kDOI Listing

Publication Analysis

Top Keywords

reversible binding
12
binding interactions
12
albumins animal
8
animal species
8
novel high
8
high performance
8
performance liquid
8
liquid chromatographic
8
human serum
8
serum albumin
8

Similar Publications

Background: This study quantified tau binding in the brain with F-PI2620 PET using a non-invasive Image-Derived Input function(IDIF), derived using a new total-body EXPLORER PET/CT scanner (Spencer et al.,2021). Additionally, we explored how PET scan duration influences the quantification of kinetic parameters across brain regions of interest(ROIs) that are vulnerable in Alzheimer's Disease.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Central Clinical School, Monash University, Melbourne, VIC, Australia.

Background: Identifying biomarkers for primary tau pathologies like Progressive Supranuclear Palsy (PSP) is crucial for diagnosis and treatment development. The novel positron emission tomography (PET) radiotracer F-PI-2620 shows promise in detecting tau protein in PSP and this study investigates its correlation with clinical markers.

Methods: We conducted a cross-sectional analysis on 20 patients with clinically diagnosed probable PSP (Richardson's Syndrome), who underwent T1-weighted MRI, lumbar puncture, blood testing, and 0-60 min dynamic F-PI-2620 PET scanning.

View Article and Find Full Text PDF

Pancreatic cancer (PC) is one of the leading causes of cancer deaths, associated with a high risk of metastasis and mortality. The long non-coding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is highly expressed in multiple types of tumour tissues and may be associated with the growth of PC cells. In this study, we aimed to assess the role and possible mechanisms of MALAT1 in PC progression.

View Article and Find Full Text PDF

Background: While the formation of β-amyloid plaques and neurofibrillary "tau" tangles are considered hallmarks of AD pathology, therapeutic targeting of these pathways has been unsuccessful, highlighting the necessity to define the underlying molecular mechanisms driving AD progression. Previous studies from our lab demonstrated that mitochondrial calcium (Ca) overload through neuronal ablation of the mitochondrial Na/Ca exchanger (NCLX) is sufficient to trigger 'AD-like' pathology, including mitochondrial dysfunction, amyloid deposition and tau pathology, and cognitive decline. In addition, we found significant proteomic remodeling of components of the mitochondrial calcium uniporter channel (mtCU), the primary mediator of Ca uptake, in frontal cortex samples isolated post-mortem from patients diagnosed with non-familial/sporadic AD.

View Article and Find Full Text PDF

Background: Recent studies show that N6-methyladenosine (m6A) plays an important role in the pathogenesis of the Alzheimer's disease (AD), while the mechanisms involved were studied insufficiently.

Aims: The present study aimed to explore the effect of human insulin-like growth factor 2 (IGF2) mRNA binding proteins 2 (IGF2BP2), one of the m6A-binding proteins on the progression of AD.

Materials & Methods: The mRNA and protein expression level were determined using RT-qPCR and western blot, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!